Prof. Ligen Mo 莫立根
Chief Physician, Professor
Department of Neurosurgery, Guangxi Medical University Cancer Hospital, Nanning
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and surgical treatment of brain, skull base, and head and neck tumors. Specializes in comprehensive care for gliomas, CNS lymphomas, and germ cell tumors, plus myocutaneous flap reconstruction after head and neck tumor surgery.
Dr. Mo is Director of Neurosurgery and Professor at Guangxi Medical University Cancer Hospital. A master’s supervisor, Dr. Mo has led or participated in 15 research projects, published over 70 papers, and co-authored one monograph. Awards include two Third Prizes for Scientific and Technological Progress in Guangxi.
Professional roles
- Chair, Neuro-Oncology Professional Committee, Guangxi Anti-Cancer Association
- Chair, Brain Glioma Professional Committee, Guangxi Medical Doctor Association
- Standing Committee Member, Neuro-Oncology Professional Committee, China Anti-Cancer Association
- Member, Nervous System Tumor Expert Committee, Chinese Society of Clinical Oncology (CSCO)
Name order: in Chinese the family name comes first (Mo Ligen). Papers usually list the name as Ligen Mo or Mo L.
Selected publications
27 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Exp Neurol, 2027 (senior author): Microglial state dynamics in intracerebral hemorrhage: A systems-level integration from molecular networks to precision therapeutics. PubMed 42829066
- Medicine (Baltimore), 2022 (senior author): CNPY4 is a potential promising prognostic-related biomarker and correlated with immune infiltrates in gliomas. PubMed 35984129
- Brain Sci, 2022 (senior author): Expression and Prognostic Value of Melanoma-Associated Antigen D2 in Gliomas. PubMed 35892426
- Front Neurol, 2022 (senior author): Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma. PubMed 35832170
- Dis Markers, 2022 (senior author): Comprehensive Analysis of Phagocytosis-Related Regulators to Aid Prognostic Prediction and Immunotherapy in Patients with Low-Grade Glioma. PubMed 35510040
- Front Oncol, 2021 (senior author): Integrative Analysis of a Novel Eleven-Small Nucleolar RNA Prognostic Signature in Patients With Lower Grade Glioma. PubMed 34164339
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion